Glaucoma implant material may influence IOP

Article

A study in the September/October issue of the European Journal of Ophthalmology has shown that the silicone plate Ahmed glaucoma valve (AGV) results in lower intraocular pressure (IOP) compared with the older polypropylene plate AGV.

A study in the September/October issue of the European Journal of Ophthalmology has shown that the silicone plate Ahmed glaucoma valve (AGV) results in lower intraocular pressure (IOP) compared with the older polypropylene plate AGV.

David Miguel Hinkle and colleagues from Tulane University Health Sciences Center and Harvard Medical School, US, reviewed 25 eyes of 22 patients undergoing silicone plate AGV (FP-7) and 26 eyes of 22 patients undergoing polypropylene plate AGV (S-2) implantation.

After implantation, IOP reductions were recorded in both the FP-7 group (29.6±13.1 to 12.1±3.4 mm Hg) and the S-2 group (31.4±11.7 to 16.1±5.7 mmHg). However, the FP-7 group had a statistically lower IOP compared with the S-2 group at six and 12 months.

Based on these results, it was concluded that plate material might influence clinical outcomes.

Related Videos
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
Giulia Corradetti, MD, discusses her presentation "Functional Microperimetric Correlates of OCT Structures Features in Intermediate AMD"
At this year's ARVO meeting, Paolo Silva, MD, presented data on Protocol AA on behalf of the DRCR Retina Network
© 2024 MJH Life Sciences

All rights reserved.